Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
$295.00 – $2,950.00
Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody. The research grade sotrovimab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Product Details
- Description
- Additional information
- More Offers
| Catalog No. | C101P |
|---|---|
| Product Name | Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Summary | Recombinant Human IgG1 Kappa Monoclonal Antibody. |
| Isotype | Human IgG1 kappa. |
| Source/Host | The anti-SARS-CoV-2 spike monoclonal antibody sotrovimab biosimilar was produced in the sotrovimab biosimilar CHO cells. |
| Specificity/Sensitivity | The sotrovimab biosimilar specifically binds to the spike protein of SARS-CoV-2. |
| Form Of Antibody | 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |
| Purity | >95% by SDS-PAGE under reducing condition. |
| Shipping | The research grade sotrovimab biosimilar is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade sotrovimab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C101P: Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody
Recombinant Human IgG1 Kappa Monoclonal Antibody.
Background
What is sotrovimab biosimilar research grade? Sotrovimab is an Fc-engineered human monoclonal antibody directed against the spike protein of SARS-CoV-2. sotrovimab is a human monoclonal antibody (IgG1κ isotype). sotrovimab biosimilar uses the same protein sequences as the therapeutic antibody sotrovimab. sotrovimab/imdevimab is a combination medicine used for the treatment and prevention of COVID-19. It consists of two human monoclonal antibodies, sotrovimab and imdevimab that must be mixed together and administered as an infusion or subcutaneous injection. The combination of two antibodies is intended to prevent mutational escape. sotrovimab and imdevimab bind distinct epitopes on the RBD with dissociation constants KD of 46 and 47 pM, respectively. Please contact us if you are interested in the anti-SARS-CoV-2 spike monoclonal antibody imdevimab biosimilar.
Syd Labs also provides the following research grade anti-SARS-CoV-2 spike antibody biosimilar proteins:
Casirivimab biosimilar, research grade, SARS-CoV-2 spike monoclonal antibody
Please remember our product information: Sotrovimab Biosimilar, SARS-CoV-2 Spike Monoclonal Antibody: C101P Syd Labs
Additional information
| Ship from Country | USA |
|---|---|
| Size | 1 mg, 20 mg, 5 mg |